Skip to main content
logo
Biogen Pharmachem Industries Limited (BOM:531752)
India flag India · Delayed Price · Currency is INR
0.2900
-0.0100 (-3.33%)
At close: Jul 31, 2026

BOM:531752 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
25.5825.5811.987.892.524.81
Revenue Growth
113.58%113.58%51.78%215.26%-89.91%52.90%
Gross Profit
25.5825.5811.987.892.54.66
Operating Income
9.579.57-2.73.38-1.963.04
Net Income
8.68.6-2.9319.314.56-0.09
Earnings Per Share
0.010.01-0.000.030.01-0.00
EPS Growth
---323.91%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
3.223.2220.160.171.290.83
Total Debt
------
Net Cash (Debt)
3.223.2220.160.171.290.83
Net Cash Growth
-84.05%-84.05%11830.77%-86.87%54.69%-
Net Cash Per Share
0.000.000.030.000.000.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
15.6815.68-10.8219.4517.0413.98
Free Cash Flow
15.6815.68-10.8219.4517.0413.98
Free Cash Flow Growth
---14.09%21.89%-64.60%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%18.79%
Operating Margin
37.40%37.40%-22.54%42.87%-78.19%12.24%
Pretax Margin
37.40%37.40%-22.53%244.67%186.50%-0.35%
Profit Margin
33.60%33.60%-24.44%244.67%181.98%-0.35%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
33.7238.72-35.8384.53-
PS Ratio
8.6313.0152.3187.67153.8336.83